Health-related quality of life in lung cancer patients in Serbia: Correlation with socio-economic and clinical parameters

European Journal of Cancer Care

Volumn 19, Issue 5, 2010, Pages 594-602

  Maric, D ^a   Jovanovic, D ^a   Golubicic, I ^b   Dimic, S ^a   Pekmezovic, T ^c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Chemotherapy; Emesis; Lung cancer; Quality of life; Socio economic factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HEALTH STATUS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; NAUSEA; QUALITY OF LIFE; QUESTIONNAIRE; SERBIA; SOCIOECONOMICS; VOMITING;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; QUALITY OF LIFE; QUESTIONNAIRES; SERBIA; SOCIOECONOMIC FACTORS; VOMITING;

EID: 77955738600     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01101.x     Document Type: Article

References (36)

1. Aaronson NK, Ahmedazai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-c 30: a quality of life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993, 85:365-376.
2. Aaronson NK, Cull AM, Kaasa S, Sprangers MAG. The European Organization for Research and Treatment of Cancer (EORTC) Modular approach to quality of life assessment in oncology: an update. Quality of Life and Pharamcoeconomics in Clinical Trials 1996, 179-188. Spilcer B, In, 2nd, edn (ed., pp., Lippincott-Raven Publishers, Philadelphia, PA, USA
3. Anderson H, Hopwood P, Stephens RJ, Thatcher N, Cottier B, Nicolson M, Milroy R, Maughan TS, Falk S, Bond MG, Burt PA, Connolly CK, McIllmurray MB, Carmichael J. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomised trial with quality of life as the primary outcome. British Journal of Cancer 2000, 83:447-453.
4. Barbareschi G, Sanderman R, Tuinstra J, van Sonderen E, Ranchor AV. A prospective study of educational level and adaptation to cancer, within one year after diagnosis, in an older population. Psychooncology 2008, 17:373-382.
5. Belani CP, Pereira JR, Von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Fossella F. Effect of chemotherapy for advanced non-small cell lung cancer on patient's quality of life. A randomised controlled trial. Lung Cancer 2006, 53:231-239. TAX 326 Study Group
6. Brown S, Thorpe H, Napp V, Brown J. Closeness to death and quality of life in advanced lung cancer patients. Clinical Oncology 2007, 19:341-348.
7. Coates AS, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MH. On the receiving end: patient's perception of the side effects of chemotherapy. European Journal of Cancer & Clinical Oncology 1983, 19:203-208.
8. Cullen MH, Billingham LJ, Woodroffe CM, Chetiyawardana AD, Gower NH, Joshi R, Ferry DR, Rudd RM, Spiro SG, Cook JE, Trask C, Bessell E, Connolly CK, Tobias J, Souhami RL. Mitomcyin, ifosfamid, and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life. Journal of Clinical Oncology 1999, 17:3188-3194.
9. Dancey J, Shepherd FA, Gralla RJ, Kim YS. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomised phase III trial. Lung Cancer 2004, 43:183-194.
10. DeVita VTJ, Hellman S, Rosenberg SA. Cancer Principles and Practice of Oncology 2004, 7th, edn., Lippincott-Raven, Philadelphia, PA, USA
11. Fallowfield LJ, Harper P. Health-related quality of life in patients undergoing drug therapy for advanced non-small cell lung cancer. Lung Cancer 2005, 48:365-377.
12. Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MHN. On the receiving end: patient's perception of the side effects of cancer chemotherapy in 1993. Annals of Oncology 1996, 7:189-195.
13. Hein HO, Suadicani P, Gyntelberg F. Lung cancer risk and social class. Danish Medical Bulletin 1992, 39:173-176.
14. Holzner B, Kemmler G, Greil R, Kopp M, Zeimet A, Raderer M, Hejna M, Zöchbauer S, Krajnik G, Huber H, Fleischhacker WW, Sperner-Unterweger B. The impact of haemoglobin levels on fatigue and quality of life in cancer patients. Annals of Oncology 2002, 13:965-973.
15. Hopwood R, Stephensen RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality of life data. Journal of Clinical Oncology 2000, 18:893-903.
16. Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C, Grey-Amante P, Doll H, Wild D. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. British Journal of Cancer 2002, 86:1243-1249.
17. Lindley CM, Hirsh JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT. Quality of life consequences of chemotherapy-induced emesis. Quality of Life Research 1992, 1:331-340.
18. Litwin MS, McGuigan KA, Shpall AI, Dhanani N. Recovery of health-related quality of life in the year after radical prostatectomy: early experience. The Journal of Urology 1999, 161:515-519.
19. Manser R, Wright G, Byrnes G, Hart D, Conron M, Carter R, McLachlan S, Campbell DA. Validity of assessment of quality of life (AQoL) utility instrument in patients with operable and inoperable lung cancer. Lung Cancer 2006, 53:217-229.
20. Martin CM, Rubenstein BE, Elting SL, Kim YJ, Osoba D. Measuring chemotherapy-induced nausea and emesis. Cancer 2003, 98:645-655.
21. Max Parkin D, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. A Cancer Journal for Clinicians 2005, 55:75-108.
22. Mohan A, Mohan C, Bhutani M, Pathak AK, Pal H, Das C, Guleria R. Quality of life in newly diagnosed patients with lung cancer in developing country: is it important? European Journal of Cancer Care 2006, 15:293-298.
23. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients as an important prognostic factor. Lung Cancer 2001, 341:233-240.
24. Montazeri A, Hole DJ, Milroy R, McEwen J, Gillis CR. Quality of life in lung cancer patients: does socioeconomic status matter? Health and Quality of Life Outcomes 2003, 1:19.
25. Chemotherapy in non-small cell lung cancer: a meta analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal 1995, 311:899-909. Non-Small Cell Lung Cancer Collaborative Group
26. Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. The association between socioeconomic status, health insurance coverage, and quality of life in man with prostate cancer. Journal of Clinical Epidemiology 2001, 54:350-358.
27. Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, Lopez P, Anderson H, Gustafson N, Jeynes A, Gallant G, Washington T, Thatcher N. Randomised trial of paclitaxel plus supportive care vs supportive care for patients with advanced non-small cell lung cancer. Journal of the National Cancer Institute 2000, 92:1074-1080.
28. Roszkowski K, Pluzanska A, Krzakowski M, Smith AP, Saigi E, Aasebo U, Parisi A, Tran NP, Olivares R, Berille J. A multicenter, randomised, phase III study of docetaxel plus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer 2000, 27:145-157.
29. Sarna L. Women with lung cancer: impact on quality of life. Quality of Life Research 1993, 2:13-22.
30. SF-36 Health Survey (Original Version) Language Recalls. http://www.qualitymetric.com, Available at: (retrieved 10 January 2007
31. Simon EA, Wardle J. Socioeconomic disparities in psychosocial wellbeing in cancer patients. European Journal of Cancer 2008, 44:572-578.
32. Socinski MA, Morris DE, Masters GA, Lilenbaum R. Chemotherapeutic manangement of stage IV non-small cell lung cancer. Chest 2003, 123:226-243.
33. Effects of vinorelbin on quality of life and survival of elderly patients with advanced non-small cell lung cancer. Journal of the National Cancer Institute 1999, 91:66-72. The Elderly Lung Cancer Vinorelbin Italian Study Group
34. Guidelines for Assessing Quality of Life in EORTC Clinical Trials 1999, The EORTC Quality Of Life Study Group and EORTC Quality Of Life Unit, EORTC Quality Of Life Study Group, Brussels, Belgium
35. Thongprasert S, Sanuganmitra P, Juthapan N, Clinch J. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) vs BSC plus chemotherapy. Lung Cancer 1999, 24:17-25.
36. Van Loon AJ, Goldbohm RA, van den Brandt PA. Lung cancer: is there an association with socioeconomic status in the Netherlands? Journal of Epidemiology and Community Health 1995, 49:65-66.